World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 83 953 854 438 372 272 47409
Medicine 83 15346 14431 7738 7155 320 47921

Paul A. Volberding publications per year

The chart shows the history of publications by Paul A. Volberding between 1952 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Paul A. Volberding published across 74 years, from 1952 to 2025, averaging 4.5 papers a year. Output peaked at 19 publications in 2020. 4 of the 333 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1952 to 2025. Vertical axis: number of publications, 0 to 19. Peak 19 publications in 2020. 1952: 1 publication 1953: 0 publications 1954: 0 publications 1955: 0 publications 1956: 0 publications 1957: 0 publications 1958: 0 publications 1959: 0 publications 1960: 0 publications 1961: 0 publications 1962: 0 publications 1963: 0 publications 1964: 0 publications 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 1 publication 1978: 0 publications 1979: 2 publications 1980: 1 publication 1981: 1 publication 1982: 3 publications 1983: 6 publications 1984: 14 publications 1985: 17 publications 1986: 14 publications 1987: 12 publications 1988: 8 publications 1989: 16 publications 1990: 10 publications 1991: 15 publications 1992: 9 publications 1993: 5 publications 1994: 12 publications 1995: 8 publications 1996: 10 publications 1997: 6 publications 1998: 4 publications 1999: 6 publications 2000: 5 publications 2001: 4 publications 2002: 9 publications 2003: 5 publications 2004: 7 publications 2005: 4 publications 2006: 7 publications 2007: 9 publications 2008: 3 publications 2009: 3 publications 2010: 6 publications 2011: 6 publications 2012: 9 publications 2013: 3 publications 2014: 4 publications 2015: 6 publications 2016: 7 publications 2017: 7 publications 2018: 5 publications 2019: 8 publications 2020: 19 publications 2021: 5 publications 2022: 2 publications 2023: 5 publications 2024: 3 publications 2025: 1 publication
1952 2025

333 publications in total across all disciplines

View publications per year as a table
Paul A. Volberding: publications per year, 1952 to 2025
Year Publications
1952 1
1953 0
1954 0
1955 0
1956 0
1957 0
1958 0
1959 0
1960 0
1961 0
1962 0
1963 0
1964 0
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 0
1972 0
1973 0
1974 0
1975 0
1976 0
1977 1
1978 0
1979 2
1980 1
1981 1
1982 3
1983 6
1984 14
1985 17
1986 14
1987 12
1988 8
1989 16
1990 10
1991 15
1992 9
1993 5
1994 12
1995 8
1996 10
1997 6
1998 4
1999 6
2000 5
2001 4
2002 9
2003 5
2004 7
2005 4
2006 7
2007 9
2008 3
2009 3
2010 6
2011 6
2012 9
2013 3
2014 4
2015 6
2016 7
2017 7
2018 5
2019 8
2020 19
2021 5
2022 2
2023 5
2024 3
2025 1
Total 333
Download as CSV

Paul A. Volberding publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Paul A. Volberding sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 265–274 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 272 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139 272
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Paul A. Volberding D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul A. Volberding sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 83 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77 83
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Research.com Recognitions

  • 1999 - Member of the National Academy of Medicine (NAM)
  • 1995 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Paul A. Volberding is affiliated with the University of California, San Francisco in the United States. Their primary field of study is Medicine, with a particular focus on infectious diseases, epidemiology, virology, emergency medicine, and hepatology.

Their research work centers largely on HIV/AIDS-related topics. The main areas covered include HIV/AIDS research and interventions, HIV research and treatment, HIV-related health complications and treatments, HIV, drug use, sexual risk, HIV/AIDS drug development and treatment, as well as hepatitis C and B virus studies.

Volberding has published extensively in various scientific venues, with notable frequent publications appearing in UNC Libraries, AIDS and Behavior, JAMA, Proceedings of the National Academy of Sciences, and BMC Infectious Diseases.

Selected recent papers by Volberding include:

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults (2020, JAMA)
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel (2020, UNC Libraries)
  • HIV post-treatment controllers have distinct immunological and virological features (2023, Proceedings of the National Academy of Sciences)
  • Anemia risk factors among people living with HIV across the United States in the current treatment era: a clinical cohort study (2020, BMC Infectious Diseases)
  • The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system (2021, Drug and Alcohol Dependence)

Frequent co-authors who have collaborated with Volberding include:

  • Joseph J. Eron
  • Michael S. Saag
  • Jonathan Z. Li
  • Rajesh T. Gandhi
  • Elizabeth Connick

Volberding's contributions span important subfields such as infectious diseases, epidemiology, and virology. Their work often addresses overlapping topics in HIV treatment and management, as well as associated health concerns in affected populations.

The scientist has been recognized by several institutions. Awards include membership in the National Academy of Medicine since 1999, fellowship of the American Association for the Advancement of Science awarded in 1995, and membership in the Association of American Physicians.

Best Publications

  • The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo-controlled trial.

    Margaret A Fischl;D. D. Richman;M. H. Grieco;M. S. Gottlieb

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter

    Paul A. Volberding;Stephen W. Lagakos;Matthew A. Koch;David K. Booth

  • The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

    Unknown

  • Non-Hodgkin's Lymphoma in 90 Homosexual Men: Relation to Generalized Lymphadenopathy and the Acquired Immunodeficiency Syndrome

    John L. Ziegler;Jay A. Beckstead;Paul A. Volberding;Donald I. Abrams

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

    Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society—USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, placebo-controlled trial

    M. A. Fischl;D. D. Richman;N. Hansen;A. C. Collier

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Antiretroviral Treatment of Adult HIV Infection

    Scott M. Hammer;Joseph J. Eron;Peter Reiss;Robert T. Schooley

  • Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

    Charles C. J. Carpenter;Margaret A. Fischl;Scott M. Hammer;Martin S. Hirsch

  • HIV viral load markers in clinical practice

    M S Saag;M Holodniy;D R Kuritzkes;W A O'Brien

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • HIV and aging: State of knowledge and areas of critical need for research. a report to the NIH office of AIDS research by the HIV and aging working group

    Kevin P. High;Mark Brennan-Ing;David B. Clifford;Mardge H. Cohen

  • AIDS-Associated Non-Hodgkin's Lymphoma in San Francisco

    Lawrence D. Kaplan;Donald I. Abrams;Ellen Feigal;Michael McGrath

Frequent Co-Authors

Donald I. Abrams
Donald I. Abrams University of California, San Francisco
Margaret A. Fischl
Margaret A. Fischl University of Miami
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
Robert T. Schooley
Robert T. Schooley University of California, San Diego
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Jerome E. Groopman
Jerome E. Groopman Beth Israel Deaconess Medical Center
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
Derek D. Satre
Derek D. Satre University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related online degrees and career pathways. For individuals with unique challenges, such as criminal records, exploring the best degree for felons can be an important first step to gaining relevant education and improving employment prospects.

Healthcare careers also complement a microbiology background. For example, becoming a functional medicine np allows professionals to integrate holistic approaches with medical knowledge, benefiting patient care through a deeper understanding of microbiological impacts on health.

For those interested in the administrative side of health sciences, certifications like cpc provide valuable skills in medical coding, essential for accurate health records management and billing processes.

Additionally, careers in health data, such as health information management job description and salary, offer promising opportunities that blend data expertise with healthcare knowledge, making it a smart choice for microbiology graduates seeking diverse roles.

Best Scientists Citing Paul A. Volberding

Trending Scientists

Recently Published Articles